Renascience Inc. (TYO:4889)

Renascience Statistics

Total Valuation

Renascience has a market cap or net worth of JPY 26.80 billion. The enterprise value is 24.39 billion.

Market Cap	26.80B
Enterprise Value	24.39B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Renascience has 13.25 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	13.25M
Shares Outstanding	13.25M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	23.55%
Owned by Institutions (%)	1.56%
Float	10.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	250.51
PB Ratio	11.09
P/TBV Ratio	11.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-94.16
EV / Sales	227.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.78

Current Ratio	17.78
Quick Ratio	17.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -12.40% and return on invested capital (ROIC) is -29,400.00%.

Return on Equity (ROE)	-12.40%
Return on Assets (ROA)	-8.23%
Return on Invested Capital (ROIC)	-29,400.00%
Return on Capital Employed (ROCE)	-12.17%
Weighted Average Cost of Capital (WACC)	15.25%
Revenue Per Employee	35.67M
Profits Per Employee	-86.33M
Employee Count	3
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

In the past 12 months, Renascience has paid 2.00 million in taxes.

Income Tax	2.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +53.20% in the last 52 weeks. The beta is 2.00, so Renascience's price volatility has been higher than the market average.

Beta (5Y)	2.00
52-Week Price Change	+53.20%
50-Day Moving Average	1,616.36
200-Day Moving Average	1,964.74
Relative Strength Index (RSI)	65.62
Average Volume (20 Days)	523,070

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Renascience had revenue of JPY 107.00 million and -259.00 million in losses. Loss per share was -20.35.

Revenue	107.00M
Gross Profit	102.00M
Operating Income	-294.00M
Pretax Income	-257.00M
Net Income	-259.00M
EBITDA	n/a
EBIT	-294.00M
Loss Per Share	-20.35

Balance Sheet

The company has 2.42 billion in cash and n/a in debt, with a net cash position of 2.42 billion or 182.41 per share.

Cash & Cash Equivalents	2.42B
Total Debt	n/a
Net Cash	2.42B
Net Cash Per Share	182.41
Equity (Book Value)	2.42B
Book Value Per Share	189.30
Working Capital	2.42B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 95.33%, with operating and profit margins of -274.77% and -242.06%.

Gross Margin	95.33%
Operating Margin	-274.77%
Pretax Margin	-240.19%
Profit Margin	-242.06%
EBITDA Margin	n/a
EBIT Margin	-274.77%
FCF Margin	n/a

Dividends & Yields

Renascience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	-0.10%
Earnings Yield	-0.97%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Renascience has an Altman Z-Score of 90.91 and a Piotroski F-Score of 1.

Altman Z-Score	90.91
Piotroski F-Score	1